Calcionics Appoints Daniel O. Wilds Executive Chairman
Mr. Wilds recently retired as CEO of SCOLR Pharma, Inc. He previously served as Chairman and CEO at Northwest Biotherapeutics, Inc., as CEO at Shiloov Biotechnologies (USA), as CEO of Adeza BioMedical, and as CEO of Medisense, Inc. Mr. Wilds started his career at Baxter International in 1968 where he held various domestic and international senior management positions for more than 20 years including being president of Baxter’s chemotherapy service business and of Travenol-Genentech, a joint venture between Baxter and Genentech. He currently serves on the board of directors of Helix BioMedix, Inc.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.